These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


159 related items for PubMed ID: 2441635

  • 1. Antiviral treatment of chronic type B hepatitis.
    Hoofnagle JH.
    Ann Intern Med; 1987 Sep; 107(3):414-5. PubMed ID: 2441635
    [No Abstract] [Full Text] [Related]

  • 2. Development and application of an in vitro model for screening anti-hepatitis B virus therapeutics.
    Lampertico P, Malter JS, Gerber MA.
    Hepatology; 1991 Mar; 13(3):422-6. PubMed ID: 1705531
    [Abstract] [Full Text] [Related]

  • 3. [Antiviral treatment of chronic hepatitis].
    Müller R.
    Internist (Berl); 1984 Dec; 25(12):728-34. PubMed ID: 6083989
    [No Abstract] [Full Text] [Related]

  • 4. Antiviral therapy in hepatitis B infection.
    Thomas HC, Scully LJ.
    Br Med Bull; 1985 Oct; 41(4):374-80. PubMed ID: 3902143
    [No Abstract] [Full Text] [Related]

  • 5. A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.
    Lok AS, Novick DM, Karayiannis P, Dunk AA, Sherlock S, Thomas HC.
    Hepatology; 1985 Oct; 5(6):1132-8. PubMed ID: 2415436
    [Abstract] [Full Text] [Related]

  • 6. Treatment of the chronic hepatitis B virus carrier state.
    Lever AM.
    J Infect; 1988 May; 16(3):221-9. PubMed ID: 2456355
    [Abstract] [Full Text] [Related]

  • 7. [Antiviral therapy].
    Suzuki H.
    Nihon Naika Gakkai Zasshi; 1984 Jun; 73(6):776-80. PubMed ID: 6208300
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of hepatitis B virus replication by adenine arabinoside monophosphate coupled to lactosaminated albumin. Efficacy and minimal active dose.
    Torrani Cerenzia MR, Fiume L, Busi C, Mattioli A, Di Stefano G, Gervasi GB, Brunetto MR, Piantino P, Verme G, Bonino F.
    J Hepatol; 1994 Feb; 20(2):307-9. PubMed ID: 7516363
    [No Abstract] [Full Text] [Related]

  • 9. Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trial.
    Garcia G, Smith CI, Weissberg JI, Eisenberg M, Bissett J, Nair PV, Mastre B, Rosno S, Roskamp D, Waterman K.
    Ann Intern Med; 1987 Sep; 107(3):278-85. PubMed ID: 2441633
    [Abstract] [Full Text] [Related]

  • 10. Combination therapy with ARA-AMP and interferon of chronic active hepatitis B. Interim analysis of an ongoing study.
    Trépo C, Rougier P, Bizollon T, Poupon R, Zarski JP, Quinton A, Miguet JP, Causse X, Chossegros P, Chevallier M.
    J Hepatol; 1991 Sep; 13 Suppl 1():S3. PubMed ID: 1720439
    [No Abstract] [Full Text] [Related]

  • 11. Therapeutic approaches to chronic hepatitis B.
    Smith CI, Merigan TC.
    Prog Liver Dis; 1982 Sep; 7():481-94. PubMed ID: 6180455
    [No Abstract] [Full Text] [Related]

  • 12. Approaches to the treatment of hepatitis B virus and delta-related liver disease.
    Thomas HC, Lever AM, Scully LJ, Pignatelli M.
    Semin Liver Dis; 1986 Feb; 6(1):34-41. PubMed ID: 2424091
    [No Abstract] [Full Text] [Related]

  • 13. [Virostatic therapy of chronic hepatitis].
    Müller R, Klein H, Niehoff G.
    Z Gesamte Inn Med; 1988 Dec 15; 43(24):705-10. PubMed ID: 2467448
    [Abstract] [Full Text] [Related]

  • 14. Acyclovir enhances the antiviral effect of interferon in chronic hepatitis B.
    Schalm SW, Heytink RA, van Buuren HR, de Man RA.
    Lancet; 1985 Aug 17; 2(8451):358-60. PubMed ID: 2862516
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of chronic hepatitis caused by hepatitis B virus].
    Ouzan D.
    Rev Prat; 1990 May 11; 40(14):1298-300. PubMed ID: 1694296
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of chronic hepatitis B].
    Carreño V, Montaño L, Torres M.
    Rev Clin Esp; 1983 Oct 15; 171(1):73-6. PubMed ID: 6197728
    [No Abstract] [Full Text] [Related]

  • 17. Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies.
    Scully LJ, Lever AM, Yap I, Pignatelli M, Thomas HC.
    J Hepatol; 1986 Oct 15; 3 Suppl 2():S291-9. PubMed ID: 2439575
    [Abstract] [Full Text] [Related]

  • 18. Effect of vidarabine on chronic hepatitis B virus infection.
    Pollard RB, Smith JL, Neal A, Gregory PB, Merigan TC, Robinson WS.
    JAMA; 1978 Apr 21; 239(16):1648-50. PubMed ID: 633577
    [No Abstract] [Full Text] [Related]

  • 19. Therapeutic activity of vidarabine in symptomatic chronic active hepatitis related to HBV.
    Trépo C, Ouzan D, Fontanges T, Chevallier M, Chossegros P, Degos F, Chevallier P, Hantz O.
    J Hepatol; 1986 Apr 21; 3 Suppl 2():S97-105. PubMed ID: 2439581
    [Abstract] [Full Text] [Related]

  • 20. Natural history and therapy of chronic hepatitis B virus infection.
    Alexander GJ, Williams R.
    Am J Med; 1988 Aug 29; 85(2A):143-6. PubMed ID: 3044078
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.